Back
ProShares Ultra MSCI Emerging Markets Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
38
EET
ProShares Ultra MSCI Emerging Markets
Last Price:
54.00
Seasonality Move:
3.69%
Buy
71
LBPH
Longboard Pharmaceuticals
Last Price:
59.76
Seasonality Move:
76.52%
Sell
38
ProShares Ultra MSCI Emerging Markets (EET)
is a Sell
Is ProShares Ultra MSCI Emerging Markets a Buy, Sell or Hold?
- The current ProShares Ultra MSCI Emerging Markets [EET] share price is $56.16. The Score for EET is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- EET is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $59.78. The Score for LBPH is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EET Stock Price Chart
What is ProShares Ultra MSCI Emerging Markets's stock price today?
-
The ProShares Ultra MSCI Emerging Markets share price today is $56.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EET is experiencing selling pressure, which indicates risk of future bearish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $59.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing selling pressure, which indicates risk of future bearish movement.
EET Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 42.57 | Sell |
| Chaikin Money Flow: | -1777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.42 - 60.6) | Sell |
| Bollinger Bands (100): | (52.9 - 59.78) | Sell |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.63 | Buy |
| Relative Strength Index (14 RSI): | 80.51 | Buy |
| Chaikin Money Flow: | -417643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.61 - 64.55) | Buy |
| Bollinger Bands (100): | (27.56 - 49.76) | Buy |
EET Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.56 | Sell |
| 20-day SMA: | 58.43 | Sell |
| 50-day SMA: | 58.05 | Sell |
| 200-day SMA: | 53.98 | Buy |
| 8-day EMA: | 57.65 | Sell |
| 20-day EMA: | 58.32 | Sell |
| 50-day EMA: | 57.99 | Sell |
| 200-day EMA: | 54.67 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.72 | Buy |
| 20-day SMA: | 59.54 | Buy |
| 50-day SMA: | 44.08 | Buy |
| 200-day SMA: | 29.37 | Buy |
| 8-day EMA: | 59.56 | Buy |
| 20-day EMA: | 56.23 | Buy |
| 50-day EMA: | 47.87 | Buy |
| 200-day EMA: | 31.78 | Buy |
ProShares Ultra MSCI Emerging Markets Earnings Growth & EET Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.46 per share.
ProShares Ultra MSCI Emerging Markets Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||